Nice Backs Bayers Xarelto | Latest News RSS feed

Nice Backs Bayers Xarelto - Latest News

NICE backs Bayer’s Xarelto

Bayer’s prescription blood thinner Xarelto (rivaroxaban) has received a positive opinion from the National Institute for Health and Care Excellence (NICE). The recommendation is for a dose of 2.5 mg ... read more

Add your link right here

Add your story here to improve SEO, search ranking and drive traffic to your website. Your link will be permanently featured right on this page. To add a link on diferent page, just visit the page you want to show your link and click "Add your link right here". You can use search form below to find the page. read more

NICE backs Bayer’s Xarelto in new stroke and heart attack prevention use

Bayer’s Xarelto (rivaroxaban) can be funded by the NHS to prevent strokes and heart attacks in high-risk adults with coronary artery disease, NICE has said. In final draft guidance NICE recommended ... read more

Bayer’s Xarelto® (rivaroxaban) receives positive…

496 patients [5.4%]; hazard ratio, 0.76; 95% confidence interval [CI], 0.66 to 0.86; P<0.001).2 Bayer’s Xarelto® (rivaroxaban) receives positive NICE recommendation for use as an option in preventing ... read more

Looking for another news?

Bayer's Xarelto set for battle with Pradaxa after NICE recommendation

Bayer has persuaded the UK's National Institute of Health and Clinical Excellence (NICE) to back Xarelto after supplying new clinical and cost effectiveness evidence for the oral anticoagulant. NICE's ... read more

NICE backs thousands more scripts for clot-fighters Pradaxa, Xarelto, and Eliquis

Bayer and Johnson & Johnson's ($JNJ) Xarelto; and Pfizer ($PFE) and Bristol-Myers Squibb's ($BMS) Eliquis--rather than the old standby, warfarin. Only half of patients who should be taking ... read more

Portola: Xarelto Settlement Points To Improving Prospects

With FAi subdued, the normal blood coagulation cascade kicks back ... Xarelto more aggressively due to its blockbuster status. You can gauge this by the fact that Boehringer did not abandon Pradaxa in ... read more

FDA expresses doubts on Xarelto for atrial fibrillation patients

Last October, the FDA approved one new anticoagulant called Pradaxa (dabigatran), but the agency seems unlikely to approve another drug called Xarelto (rivaroxaban ... by Johnson & Johnson and Germany ... read more

10 Takeover Targets to Watch in 2019

That would fill a nice hole in AbbVie’s revenue stream and would ... Andexxa was approved as the first and only antidote indicated for patients treated with Bayer/Janssen [Johnson & Johnson]’s Xarelto ... read more

BMS, Pfizer's Eliquis gets a NICE boost in rivalry with Pradaxa, Xarelto

The National Institute for Health Care and Excellence (NICE) gave a draft OK to the drug in patients ... as the drug competes in a three-horse race with Johnson & Johnson ($JNJ) and Bayer's Xarelto ... read more

Questions raised about clinical trial of popular heart drug

The clinical trial tested a blood-thinning medication called rivaroxaban, which is now marketed under the brand name Xarelto. More than 13 million ... maker confirmed to The BMJ that the problem dated ... read more

NICE backs Bayer's Xarelto for DVT treatment

If finalised, the latest guidance could give Bayer a leg-up in the marketplace as Xarelto is "the only non-VKA oral anticoagulant to be recommended by NICE as a cost-effective DVT treatment option", ... read more

NICE backs Bayer's Xarelto for use on the NHS

Bayer has been boosted by the news that the UK’s drug cost-effectiveness watchdog has recommended that the firm’s oral anti-thrombosis treatment Xarelto has been recommended for reimbursement on the ... read more

FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us